Hypoglycemic effects of Welsh onion in an animal model of diabetes mellitus

Nutrition Research and Practice

Volumn 4, Issue 6, 2010, Pages 486-491

  Kang, Min Jung ^a   Kim, Ji Hye ^a   Choi, Ha Neul ^a   Kim, Myoung Jin ^a   Han, Jung Hee ^b   Lee, Jai Heon ^c   Kim, Jung In ^a  

^a Inje University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Dong A University   (South Korea)

Author keywords

glucosidase inhibition; Diabetes; Glucose; Glycated hemoglobin; Welsh onion

Indexed keywords

ALLIUM FISTULOSUM; ANIMALIA; MUS; RATTUS;

EID: 79953277893     PISSN: 19761457     EISSN: 20056168     Source Type: Journal    
DOI: 10.4162/nrp.2010.4.6.486     Document Type: Article

References (38)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
2. American Diabetes Association (ADA). Summary of revisions for the 2008 clinical practice recommendations. Diabetes Care 2008;31:S3-4.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
4. Abrahamson MJ. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Arch Intern Med 2004;164:486-91.
5. Standl E, Baumgartl HJ, Füchtenbusch M, Stemplinger J. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes Metab 1999;1:215-20.
6. Sels JP, Huijberts MS, Wolffenbuttel BH. Miglitol, a new alpha-glucosidase inhibitor. Expert Opin Pharmacother 1999;1:149-56.
7. Fujita H, Yamagami T, Ohshima K. Fermented soybean-derived water-soluble Touchi extract inhibits alpha-glucosidase and is antiglycemic in rats and humans after single oral treatments. J Nutr 2001;131:1211-3.
8. Shim YJ, Doo HK, Ahn SY, Kim YS, Seong JK, Park IS, Min BH. Inhibitory effect of aqueous extract from the gall of Rhus Chinensis on alpha-glucosidase activity and postprandial blood glucose. J Ethnopharmacol 2003;85:283-7.
9. Gholamhoseinian A, Fallah H, Sharififar F. Inhibitory effect of methanol extract of Rosa damascena Mill. flowers on alphaglucosidase activity and postprandial hyperglycemia in normal and diabetic rats. Phytomedicine 2009;16:935-41.
10. Joo HJ, Kang MJ, Seo TJ, Kim HA, Yoo SJ, Lee SK, Lim HJ, Byun BH, Kim JI. The hypoglycemic effect of Saururus chinensis Baill in animal models of diabetes mellitus. Food Sci Biotechnol 2006;15:413-7.
11. Wang H, Du YJ, Song HC. α-Glucosidase and α-amylase inhibitory activities of guava leaves. Food Chem 2010;123:6-13.
12. Yamamoto Y, Aoyama S, Hamaguchi N, Rhi GS. Antioxidative and antihypertensive effects of Welsh onion on rats fed with a high-fat high-sucrose diet. Biosci Biotechnol Biochem 2005;69:1311-7.
13. Yamamoto Y, Yasuoka A. Welsh onion attenuates hyperlipidemia in rats fed on high-fat high-sucrose diet. Biosci Biotechnol Biochem 2010;74:402-4.
14. Yoshino G, Hirano T, Kazumi T. Dyslipidemia in diabetes mellitus. Diabetes Res Clin Pract 1996;33:1-14.
15. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24-38.
16. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki Y. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance. Int J Biochem Cell Biol 2005;37:1595-608.
17. Youn JY, Park HY, Cho KH. Anti-hypergltcemic activity of Commelina communis L.: inhibition of α-glucosidase. Diabetes Res Clin Pract 2004;66:S149-55.
18. Watanabe J, Kawabata J, Kurihara H, Niki R. Isolation and identification of α-glucosidase inhibitors from Tochu-cha. Biosci Biotechnol Biochem 1997;61:177-8.
19. Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi Sh, Farhangi A, Allah Verdi A, Mofidian SMA, Lame Rad B. Induction of diabetes by streptozotocin in rats. Indian J Clin Biochem 2007;22:60-4.
20. Lee SK, Hwang JY, Song JH, Jo JR, Kim MJ, Kim ME, Kim JI. Inhibitory activity of Euonymus alatus against alpha-glucosidase in vitro and in vivo. Nutr Res Pract 2007;1:184-8.
21. Raabo E, Terkildsen TC. On the enzymatic determination of blood glucose. Scand J Clin Lab Invest 1960;12:402-7.
22. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
23. Schifreen RS, Hickingbotham MJ, Bowers GN Jr. Accuracy, precision, and stability in measurement of hemoglobin A1c by "high performance" cation-exchange chromatography. Clin Chem 1980;26:466-72.
24. Hanefeld M. The role of acarbose in the treatment of non-insulindependent diabetes mellitus. J Diabetes Complications 1998;12:228-37.
25. Korea Food and Drug Administration. Functional Food [Internet]. [cited 2010 Aug 30]. Available from: http://hfoodi.kfda.go.kr.
26. Saito M. Role of FOSHU (food for specified health uses) for healthier life. Yakugaku Zasshi 2007;127:407-16.
27. Haller H. The clinical importance of postprandial glucose. Diabetes Res Clin Pract 1998;40:S43-9.
28. Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 2006;16:453-6.
29. Holman RR, Cull CA, Turner RC. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 1999;22:960-4.
30. Balfour JA, McTavish D. Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 1993;46:1025-54.
31. Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study. Diabetes Care 1995;18:817-24.
32. Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D. Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care 2000;23:1162-7.
33. Lebovitz HE. α-Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Rev 1998;6:132-45.
34. Dolan PL, Tapscott EB, Peterson RG, Dohm GL. Effects of feeding acarbose on muscle glucose transport and GLUT4 protein in lean and obese diabetic (ZDFIGmi-fa) rats. J Nutr Biochem 1997;8:322-7.
35. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
36. LeRoith D, Smith DO. Monitoring glycemic control: the cornerstone of diabetes care. Clin Ther 2005;27:1489-99.
37. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
38. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.